Medical Care
Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198349
- Pages: 76
- Figures: 76
- Views: 2
The global Tuberculosis (TB) Diagnostics market size was US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
The global Tuberculosis (TB) Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
By Type: (Dominant Segment vs High-Margin Innovation)
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Diagnostic Laboratories
Hospitals
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Danaher in Europe)
- Emerging Product Trends: Culture-Based Diagnostics adoption vs. Sputum Smear Microscopy premiumization
- Demand-Side Dynamics: Diagnostic Laboratories growth in China vs. Hospitals potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Tuberculosis (TB) Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sputum Smear Microscopy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tuberculosis (TB) Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
The global Tuberculosis (TB) Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
By Type: (Dominant Segment vs High-Margin Innovation)
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Diagnostic Laboratories
Hospitals
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Danaher in Europe)
- Emerging Product Trends: Culture-Based Diagnostics adoption vs. Sputum Smear Microscopy premiumization
- Demand-Side Dynamics: Diagnostic Laboratories growth in China vs. Hospitals potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Tuberculosis (TB) Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sputum Smear Microscopy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tuberculosis (TB) Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.3 China Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.4 Japan Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.6 India Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.7 Central & South America Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Tuberculosis (TB) Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Tuberculosis (TB) Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2020-2025)
5.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Tuberculosis (TB) Diagnostics Revenue
5.4 Global Tuberculosis (TB) Diagnostics Market Concentration Analysis
5.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024
5.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served
5.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
5.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.3.2.2 China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.3.3.2 China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.4.2.2 Japan Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.4.3.2 Japan Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.6.2.2 India Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.6.3.2 India Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Danaher
7.1.1 Danaher Company Details
7.1.2 Danaher Business Overview
7.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
7.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.1.5 Danaher Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
7.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.2.5 Roche Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Details
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
7.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.3.5 Thermo Fisher Scientific Recent Development
7.4 BD
7.4.1 BD Company Details
7.4.2 BD Business Overview
7.4.3 BD Tuberculosis (TB) Diagnostics Introduction
7.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.4.5 BD Recent Development
7.5 Abbott
7.5.1 Abbott Company Details
7.5.2 Abbott Business Overview
7.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
7.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.5.5 Abbott Recent Development
7.6 Hologic
7.6.1 Hologic Company Details
7.6.2 Hologic Business Overview
7.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
7.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.6.5 Hologic Recent Development
7.7 Qiagen
7.7.1 Qiagen Company Details
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
7.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.7.5 Qiagen Recent Development
7.8 BioMerieux
7.8.1 BioMerieux Company Details
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
7.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.8.5 BioMerieux Recent Development
7.9 Hain Lifescience
7.9.1 Hain Lifescience Company Details
7.9.2 Hain Lifescience Business Overview
7.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
7.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.9.5 Hain Lifescience Recent Development
7.10 Oxford Immunotec
7.10.1 Oxford Immunotec Company Details
7.10.2 Oxford Immunotec Business Overview
7.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
7.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.10.5 Oxford Immunotec Recent Development
8 Tuberculosis (TB) Diagnostics Market Dynamics
8.1 Tuberculosis (TB) Diagnostics Industry Trends
8.2 Tuberculosis (TB) Diagnostics Market Drivers
8.3 Tuberculosis (TB) Diagnostics Market Challenges
8.4 Tuberculosis (TB) Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.3 China Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.4 Japan Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.6 India Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
2.5.7 Central & South America Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Tuberculosis (TB) Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Tuberculosis (TB) Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2020-2025)
5.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Tuberculosis (TB) Diagnostics Revenue
5.4 Global Tuberculosis (TB) Diagnostics Market Concentration Analysis
5.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024
5.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served
5.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
5.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.3.2.2 China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.3.3.2 China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.4.2.2 Japan Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.4.3.2 Japan Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.6.2.2 India Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.6.3.2 India Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Danaher
7.1.1 Danaher Company Details
7.1.2 Danaher Business Overview
7.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
7.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.1.5 Danaher Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
7.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.2.5 Roche Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Details
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
7.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.3.5 Thermo Fisher Scientific Recent Development
7.4 BD
7.4.1 BD Company Details
7.4.2 BD Business Overview
7.4.3 BD Tuberculosis (TB) Diagnostics Introduction
7.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.4.5 BD Recent Development
7.5 Abbott
7.5.1 Abbott Company Details
7.5.2 Abbott Business Overview
7.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
7.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.5.5 Abbott Recent Development
7.6 Hologic
7.6.1 Hologic Company Details
7.6.2 Hologic Business Overview
7.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
7.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.6.5 Hologic Recent Development
7.7 Qiagen
7.7.1 Qiagen Company Details
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
7.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.7.5 Qiagen Recent Development
7.8 BioMerieux
7.8.1 BioMerieux Company Details
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
7.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.8.5 BioMerieux Recent Development
7.9 Hain Lifescience
7.9.1 Hain Lifescience Company Details
7.9.2 Hain Lifescience Business Overview
7.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
7.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.9.5 Hain Lifescience Recent Development
7.10 Oxford Immunotec
7.10.1 Oxford Immunotec Company Details
7.10.2 Oxford Immunotec Business Overview
7.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
7.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
7.10.5 Oxford Immunotec Recent Development
8 Tuberculosis (TB) Diagnostics Market Dynamics
8.1 Tuberculosis (TB) Diagnostics Industry Trends
8.2 Tuberculosis (TB) Diagnostics Market Drivers
8.3 Tuberculosis (TB) Diagnostics Market Challenges
8.4 Tuberculosis (TB) Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Tuberculosis (TB) Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Tuberculosis (TB) Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Tuberculosis (TB) Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Tuberculosis (TB) Diagnostics Application
Table 18. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Table 21. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
Table 25. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 37. China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 41. Japan Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 49. India Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 51. Danaher Company Details
Table 52. Danaher Business Overview
Table 53. Danaher Tuberculosis (TB) Diagnostics Product
Table 54. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Danaher Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Tuberculosis (TB) Diagnostics Product
Table 59. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 64. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Tuberculosis (TB) Diagnostics Product
Table 69. BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 70. BD Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Tuberculosis (TB) Diagnostics Product
Table 74. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Hologic Company Details
Table 77. Hologic Business Overview
Table 78. Hologic Tuberculosis (TB) Diagnostics Product
Table 79. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Hologic Recent Development
Table 81. Qiagen Company Details
Table 82. Qiagen Business Overview
Table 83. Qiagen Tuberculosis (TB) Diagnostics Product
Table 84. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Qiagen Recent Development
Table 86. BioMerieux Company Details
Table 87. BioMerieux Business Overview
Table 88. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 89. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 90. BioMerieux Recent Development
Table 91. Hain Lifescience Company Details
Table 92. Hain Lifescience Business Overview
Table 93. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 94. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Hain Lifescience Recent Development
Table 96. Oxford Immunotec Company Details
Table 97. Oxford Immunotec Business Overview
Table 98. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 99. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Oxford Immunotec Recent Development
Table 101. Tuberculosis (TB) Diagnostics Market Trends
Table 102. Tuberculosis (TB) Diagnostics Market Drivers
Table 103. Tuberculosis (TB) Diagnostics Market Challenges
Table 104. Tuberculosis (TB) Diagnostics Market Restraints
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Product Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. Culture-Based Diagnostics Features
Figure 4. Sputum Smear Microscopy Features
Figure 5. Rapid Molecular Diagnostics Features
Figure 6. Others Features
Figure 7. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Diagnostic Laboratories
Figure 9. Hospitals
Figure 10. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 11. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Central & South America Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 22. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024
Figure 24. North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 25. North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 26. Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 27. Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 28. China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 29. China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 30. Japan Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 31. Japan Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 32. Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 33. Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 34. India Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 35. India Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 36. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 37. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 39. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 40. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 41. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 42. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 43. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 44. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 45. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Tuberculosis (TB) Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Tuberculosis (TB) Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Tuberculosis (TB) Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Tuberculosis (TB) Diagnostics Application
Table 18. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Table 21. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
Table 25. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 37. China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 41. Japan Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)
Table 49. India Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 51. Danaher Company Details
Table 52. Danaher Business Overview
Table 53. Danaher Tuberculosis (TB) Diagnostics Product
Table 54. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Danaher Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Tuberculosis (TB) Diagnostics Product
Table 59. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 64. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Tuberculosis (TB) Diagnostics Product
Table 69. BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 70. BD Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Tuberculosis (TB) Diagnostics Product
Table 74. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Hologic Company Details
Table 77. Hologic Business Overview
Table 78. Hologic Tuberculosis (TB) Diagnostics Product
Table 79. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Hologic Recent Development
Table 81. Qiagen Company Details
Table 82. Qiagen Business Overview
Table 83. Qiagen Tuberculosis (TB) Diagnostics Product
Table 84. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Qiagen Recent Development
Table 86. BioMerieux Company Details
Table 87. BioMerieux Business Overview
Table 88. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 89. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 90. BioMerieux Recent Development
Table 91. Hain Lifescience Company Details
Table 92. Hain Lifescience Business Overview
Table 93. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 94. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Hain Lifescience Recent Development
Table 96. Oxford Immunotec Company Details
Table 97. Oxford Immunotec Business Overview
Table 98. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 99. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Oxford Immunotec Recent Development
Table 101. Tuberculosis (TB) Diagnostics Market Trends
Table 102. Tuberculosis (TB) Diagnostics Market Drivers
Table 103. Tuberculosis (TB) Diagnostics Market Challenges
Table 104. Tuberculosis (TB) Diagnostics Market Restraints
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Product Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. Culture-Based Diagnostics Features
Figure 4. Sputum Smear Microscopy Features
Figure 5. Rapid Molecular Diagnostics Features
Figure 6. Others Features
Figure 7. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Diagnostic Laboratories
Figure 9. Hospitals
Figure 10. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 11. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Central & South America Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 22. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024
Figure 24. North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 25. North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 26. Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 27. Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 28. China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 29. China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 30. Japan Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 31. Japan Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 32. Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 33. Southeast Asia Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 34. India Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Figure 35. India Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 36. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 37. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 39. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 40. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 41. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 42. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 43. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 44. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 45. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232